Publication: Socio-demographic factors, beliefs and health perceptions associated with use of a commercially available Ω-3 fatty acid supplement: A cross-sectional study in Asian countries
dc.contributor.author | Benjamin Haddon Parmenter | en_US |
dc.contributor.author | Akkarach Bumrungpert | en_US |
dc.contributor.author | George Anthony Thouas | en_US |
dc.contributor.other | The University of Western Australia | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Dhurakij Pundit University | en_US |
dc.contributor.other | Max Biocare Institute | en_US |
dc.date.accessioned | 2022-08-04T07:58:31Z | |
dc.date.available | 2022-08-04T07:58:31Z | |
dc.date.issued | 2021-03-01 | en_US |
dc.description.abstract | Background: Limited studies have reported on socio-demographic factors, beliefs and health perceptions related to ω-3 supplement use in Asia. We aimed to examine characteristics associated with use of an ω-3 supplement in Asia. Methods: Adults residing in Thailand, China and Vietnam (n = 904; mean ± SD age, 31.3 ± 9.1 years; sex, 70.4 % female; education, 65.3 % to tertiary level) completed a cross-sectional survey, with 214 reporting use of the ω-3 product (Dasbrain®). Results: Use of the ω-3 product was significantly higher among those reporting higher education, income or quality of life, as well as musculoskeletal or cognitive conditions. Participants who perceived the ω-3 product as proven by research, safe, and natural were significantly more likely to use the product, as were those with higher self-perceived knowledge of ω-3. The most common perceived benefits of the ω-3 product included “support of overall health/wellbeing” (63.5 %) and “cognitive performance” (49.3 %), however, these were not associated with higher likelihood of use. Conclusion: Use of the ω-3 product is associated with higher socio-demographic status and belief in its safety and efficacy among adults residing in Asia. Users and non-users alike show similar beliefs about the potential health benefits of the ω-3 product. | en_US |
dc.identifier.citation | PharmaNutrition. Vol.15, (2021) | en_US |
dc.identifier.doi | 10.1016/j.phanu.2020.100237 | en_US |
dc.identifier.issn | 22134344 | en_US |
dc.identifier.other | 2-s2.0-85096959611 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/75725 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096959611&origin=inward | en_US |
dc.subject | Agricultural and Biological Sciences | en_US |
dc.subject | Medicine | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Socio-demographic factors, beliefs and health perceptions associated with use of a commercially available Ω-3 fatty acid supplement: A cross-sectional study in Asian countries | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096959611&origin=inward | en_US |